메뉴 건너뛰기
Cutis
Volumn 84, Issue 6, 2009, Pages 325-328
Adalimumab in the management of cutaneous and oral Lichen planus
Author keywords

[No Author keywords available]
Indexed keywords

ADALIMUMAB; ANTIINFLAMMATORY AGENT; MONOCLONAL ANTIBODY;
EID: 77949907462     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (42)
References (14)
  • 1
    • 0037284581 scopus 로고    scopus 로고
    • Erosive oral lichen planus with genital lesions: the vulvovaginal-gingival syndrome and the peno-gingival syndrome
    • Rogers RS 3rd, Eisen D. Erosive oral lichen planus with genital lesions: the vulvovaginal-gingival syndrome and the peno-gingival syndrome. Dermatol Clin. 2003;21: 91-98.
    • (2003) Dermatol Clin , vol.21 , pp. 91-98
    • Rogers R.S., 3rd.1    Eisen, D.2
  • 2
    • 0037287564 scopus 로고    scopus 로고
    • The clinical manifestations and treatment of oral lichen planus
    • Eisen D. The clinical manifestations and treatment of oral lichen planus. Dermatol Clin. 2003;21:79-89.
    • (2003) Dermatol Clin , vol.21 , pp. 79-89
    • Eisen, D.1
  • 3
    • 0345168138 scopus 로고    scopus 로고
    • Increased serum levels of tumor necrosis factor α in lichen planus
    • Erdem MT, Gulec AI, Kiziltunc A, et al. Increased serum levels of tumor necrosis factor α in lichen planus. Dermatology. 2003;207:367-370.
    • (2003) Dermatology , vol.207 , pp. 367-370
    • Erdem, M.T.1    Gulec, A.I.2    Kiziltunc, A.3
  • 4
    • 0032417121 scopus 로고    scopus 로고
    • Treatment of lichen planus. an evidence-based medicine analysis of efficacy
    • Cribier B, Frances C, Chosidow O. Treatment of lichen planus. an evidence-based medicine analysis of efficacy. Arch Dermatol. 1998;134:1521-1530.
    • (1998) Arch Dermatol , vol.134 , pp. 1521-1530
    • Cribier, B.1    Frances, C.2    Chosidow, O.3
  • 5
    • 28444474150 scopus 로고    scopus 로고
    • Number V oral lichen planus: clinical features and management
    • Eisen D, Carrozzo M, Bagan Sebastian JV, et al. Number V oral lichen planus: clinical features and management. Oral Dis. 2005;11:338-349.
    • (2005) Oral Dis , vol.11 , pp. 338-349
    • Eisen, D.1    Carrozzo, M.2    Bagan Sebastian, J.V.3
  • 6
    • 0038322120 scopus 로고    scopus 로고
    • Oral lichen planus: causes, diagnosis and management
    • Sugerman PB, Savage NW. Oral lichen planus: causes, diagnosis and management. Aust Dent J. 2002;47: 290-297.
    • (2002) Aust Dent J , vol.47 , pp. 290-297
    • Sugerman, P.B.1    Savage, N.W.2
  • 7
    • 9444281801 scopus 로고    scopus 로고
    • Lichen planus
    • Goldblum OM. Lichen planus. Skinmed. 2002;1: 52-53.
    • (2002) Skinmed , vol.1 , pp. 52-53
    • Goldblum, O.M.1
  • 8
    • 0033842069 scopus 로고    scopus 로고
    • TNF-a expression and apoptosis-regulating proteins in oral lichen planus: a comparative immunohistochemical evaluation
    • Sklavounou A, Chrysomali E, Scorilas A, et al. TNF-a expression and apoptosis-regulating proteins in oral lichen planus: a comparative immunohistochemical evaluation. J Oral Pathol Med. 2000;29:370-375.
    • (2000) J Oral Pathol Med , vol.29 , pp. 370-375
    • Sklavounou, A.1    Chrysomali, E.2    Scorilas, A.3
  • 9
    • 8244261383 scopus 로고    scopus 로고
    • In situ expression and serum levels of tumour necrosis factor α receptors in patients with lichen planus
    • Simon M Jr, Gruschwitz MS. In situ expression and serum levels of tumour necrosis factor α receptors in patients with lichen planus. Acta Derm Venereol. 1997;77: 191-193.
    • (1997) Acta Derm Venereol , vol.77 , pp. 191-193
    • Simon M., Jr.1    Gruschwitz, M.S.2
  • 10
    • 33749835974 scopus 로고    scopus 로고
    • Fatal erosive lichen planus
    • Sheth N, Bull R, Cerio R, et al. Fatal erosive lichen planus. Br J Dermatol. 2006;155:1075-1076.
    • (2006) Br J Dermatol , vol.155 , pp. 1075-1076
    • Sheth, N.1    Bull, R.2    Cerio, R.3
  • 11
    • 34047275267 scopus 로고    scopus 로고
    • Lichen planus responding to efalizumab
    • Böhm M, Luger TA. Lichen planus responding to efalizumab. J Am Acad Dermatol. 2007;56(suppl 5):S92-S93.
    • (2007) J Am Acad Dermatol , vol.56 , Issue.SUPPL 5
    • Böhm, M.1    Luger, T.A.2
  • 12
    • 36849070806 scopus 로고    scopus 로고
    • Impact of adalimumab treatment on patient-reported outcomes: results from a phase III clinical trial in patients with moderate to severe plaque psoriasis
    • Revicki DA, Willian MK, Menter A, et al. Impact of adalimumab treatment on patient-reported outcomes: results from a phase III clinical trial in patients with moderate to severe plaque psoriasis. J Dermatolog Treat. 2007;18:341-350.
    • (2007) J Dermatolog Treat , vol.18 , pp. 341-350
    • Revicki, D.A.1    Willian, M.K.2    Menter, A.3
  • 13
    • 39049133924 scopus 로고    scopus 로고
    • Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis
    • Revicki D, Willian MK, Saurat JH, et al. Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis. Br J Dermatol. 2008;158:549-557.
    • (2008) Br J Dermatol , vol.158 , pp. 549-557
    • Revicki, D.1    Willian, M.K.2    Saurat, J.H.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.